期刊文献+

AKT/mTOR信号通路在喉癌组织中的表达及意义 被引量:14

Expression and Significance of AKT/mTOR Signal Pathway in Laryngeal Cancer
暂未订购
导出
摘要 【目的】研究AKT/mTOR信号通路在喉鳞状细胞癌组织中的表达及其与临床病理因素之间的关系。【方法】用免疫组化染色测定p-AKT和p-mTOR在喉癌(84例)、癌旁(24例)和正常黏膜组织(20例)中的表达情况,分析其与常见临床病理因素之间的关系。【结果】p-AKT在喉癌、癌旁和正常黏膜组织中的阳性表达分别为78.3%、29.2%、25%,p-mTOR在喉癌、癌旁和正常黏膜组织中的阳性表达分别为76.4%、50%、20%;AKT/mTOR信号通路的过度表达在喉癌、癌旁和正常黏膜组织中的表达呈递减的趋势;喉鳞状细胞癌组织中p-Akt与p-mTOR蛋白的表达呈正相关;此通路在喉癌组织中的表达与病理分化程度呈负相关性。【结论】AKT/mTOR信号通路在大部分喉癌组织中过度表达,可能是喉癌发生发展的重要机制之一。 [Objective] This study aimed to explore the expression of AKT/mTOR (Protein kinase B/mammalian target of rapamycin) signal pathway in laryngeal squamous cell cancer and the relationship between the expression with the clinical and pathological factors in laryngeal cancer. [Method] The expression of p-AKT and p-mTOR in laryngeal cancer (84 cases), paracancer (24 cases) and normal mucosa tissues (20 cases) were measured by immunohistochemical test, and then their relationship with clinical and pathological factors were analyzed. [Result] The expression of p-AKT in laryngeal cancer, paracancer and normal mucosa tissues were 78.3%, 29.2%, and 25%, respectively. And the expression of p-mTOR were 76.4%, 50%, and 20%, respectively. The expression of AKT/mTOR signal pathway decreased gradually in these specimens. The expression of p-AKT and p-mTOR in laryngeal cancer were positively relative. Furthermore, the expression of this signal pathway was negatively associated with the pathological differentiation degree. [Conclusion] AKT/mTOR signal pathway over expressed in most of laryngeal cancer. It may play an important role in occurrence and development of laryngeal cancer.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2009年第1期35-38,42,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省自然科学基金博士科研启动基金(5300781) 广东省科技计划项目(60501022)
关键词 AKT MTOR 喉癌 病理分化 protein kinase B mammalian target of rapamycin laryngeal cancer pathological differentiation
  • 相关文献

参考文献12

  • 1Shamji AF, Nghiem P, Schreiber SI,. Integration of growth factor anti nutrient signaling: implications for cancer biology [ J ]. Mol Cell, 2003,12 (2) : 271-280.
  • 2Ayanta D, Stephanie JW, Joan SB. Akt activation disrupts mammary aeinar architecture and enhances proliferation in an mTOR-dependent manner [ J]. J Cell Biol, 2003,163(2) :315-326.
  • 3张大勇,黄中新.Sonic hedgehog信号通路在肺发育及肺癌发生中的意义[J].解剖学研究,2007,29(1):68-72. 被引量:1
  • 4张浩,颜建华,李永平.Hedgehog信号分子在视网膜母细胞瘤中的表达[J].中山大学学报(医学科学版),2007,28(B06):24-26. 被引量:4
  • 5温星桥,李小娟,罗云,王林,周祥福,蔡育彬,温机灵,高新.生育酚结合蛋白通过磷酸肌醇3激酶途径抑制前列腺癌的生长[J].中山大学学报(医学科学版),2007,28(4):367-372. 被引量:4
  • 6Lin H J, Hsieh FC, Song H, et al. Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer [J]. Br J Cancer, 2005,93 (12) : 1372-1381.
  • 7Tsurutani J, West KA, Sayyah J, et al. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinih mesylate or chemotherapy [J]. Cancer Res, 2005,65 (18) :8423- 8432.
  • 8Takeuchi H, Kondo Y, Fujiwara K, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/ protein kinase B inhibitors [J]. Cancer Res, 2005,65 (8) :3336-3346.
  • 9Keith CT, Schreiber SL. PIK-related kinases: DNA repair, recombination, and cell cycle checkpoint [J]. Science, 1995,270(5233) :50-51.
  • 10Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy [J]. Nat rev Cancer, 2004,4(5): 335-348.

二级参考文献59

共引文献6

同被引文献129

引证文献14

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部